Invention Grant
US09588119B2 In vitro method of inhibiting the growth of radioresistant laryngeal cancer cells 有权
抑制放射抗性喉癌细胞生长的体外方法

In vitro method of inhibiting the growth of radioresistant laryngeal cancer cells
Abstract:
Disclosed are increased expression of ERp57, ERp57-STAT3 complex, and ERp57-STAT3-Mcl-1 in laryngeal cancer, especially in radioresistant laryngeal cancer and their regulations on radioresistance of laryngeal cancer. As such, the efficacy of radiotherapy can be enhanced by diagnosing prognosis in laryngeal cancer and radioresistance of laryngeal cancer. Furthermore, provided are a method of screening a therapeutic agent for laryngeal cancer including selecting a candidate drug that inhibits the expression of ERp57 or inactivates ERp57, and a therapeutic method for inhibiting or treating laryngeal cancer or radioresistant laryngeal cancer, thereby being useful in the treatment of laryngeal cancer.
Information query
Patent Agency Ranking
0/0